The Ninth Annual Food and Drug Administration-Orange County Regulatory Affairs Educational Conference, 14533 [E6-4092]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 55 / Wednesday, March 22, 2006 / Notices
cprice-sewell on PROD1PC70 with NOTICES
from regions that have reported the
presence of highly pathogenic avian
influenza H5N1 in poultry. (See 70
Federal Register 41608 [July 20, 2005].)
As the United Nations Food and
Agriculture Organization and the World
Organization for Animal Health (OIE)
have confirmed additional cases of
highly pathogenic avian influenza
(H5N1), USDA/APHIS has added
additional countries to its ban. On
December 29, 2005, HHS/CDC added
the Republic of Kazakhstan, Romania,
the Russian Federation, the Republic of
Turkey, and Ukraine to its current
embargo because of documented cases
of highly pathogenic avian influenza
H5N1 in poultry in those countries. On
February 8, 2006, HHS/CDC added
Nigeria to its embargo because of the
documentation of highly pathogenic
avian influenza H5N1 in poultry. On
February 22, 2006, HHS/CDC added
India to its embargo because of
documentation of highly pathogenic
avian influenza H5N1 in poultry. On
February 27, 2006, added Egypt to its
embargo because of documentation of
highly pathogenic avian influenza H5N1
in poultry. On March 2, 2006, CDC
issued an amendment adding Niger to
its embargo after H5N1 was confirmed
in poultry.
On February 24, 2006, OIE reported
confirmation of highly pathogenic avian
influenza H5N1 in poultry in
Azerbaijan. On March 7, 2006, OIE
reported confirmation of highly
pathogenic avian influenza H5N1 in
poultry in Albania. On March 11, 2006,
OIE reported confirmation of highly
pathogenic avian influenza H5N1 in
poultry in Cameroon. On March 12,
2006, OIE reported confirmation of
highly pathogenic avian influenza H5N1
in poultry in Myanmar. USDA/APHIS
subsequently added Albania,
Azerbaijan, Cameroon, and Myanmar to
their ban. At this time, HHS/CDC is
adding Albania, Azerbaijan, Cameroon,
and Myanmar to its current embargo.
This action is effective on March 15,
2006, and will remain in effect until
further notice.
SUPPLEMENTARY INFORMATION:
Background
On February 24, OIE reported
laboratory confirmation of highly
pathogenic avian influenza in poultry in
Azerbaijan.
On March 10, OIE reported laboratory
confirmation of highly pathogenic avian
influenza H5N1 in poultry in Albania in
the village of Cuke, Sarande County
(Viore State). The outbreak began on
February 16, 2006.
An outbreak of avian influenza due to
highly pathogenic virus H5N1 was
VerDate Aug<31>2005
14:47 Mar 21, 2006
Jkt 208001
repoted in duck farms in Doualare area
in Maroua, Cameroon. The outbreak
began on February 21, 2006, and
confirmation of infection was reported
by OIE on March 12, 2006.
An outbreak of highly pathogenic
avian influenza subtype H5N1 was
reported in poultry at Aung Myae Thar
Zan Township, in Mandalay Division,
Myanmar. The outbreak began on March
8, 2006, and confirmation of infection
was reported by OIE on March 12, 2006.
Introduction of birds infected with
highly pathogenic avian influenza H5N1
into the United States could lead to
outbreaks among birds and among the
human population, a significant public
health threat. Banning the importation
of all avian species from affected
countries is an effective menas of
limiting this threat. HHS/CDC is
therefore taking this action to reduce the
chance of introduction or spread of
influenza A H5N1 into the United
States.
14533
Food and Drug Administration
conference is intended to provide the
drug, device, and biologics industries
with an opportunity to interact with
FDA reviewers and compliance officers
from the centers and district offices, as
well as other industry experts. The main
focus of this interactive conference will
be product approval, compliance, and
risk management in the three medical
product areas. Industry speakers,
interactive question and answer, and
workshop sessions will also be included
to assure open exchange and dialogue
on the relevant regulatory issues.
Date and Time: The conference will
be held on May 23 and 24, 2006, from
7:30 a.m. to 5 p.m.
Location: The conference will be held
at the Fairmont Newport Beach Hotel,
4500 MacArthur Blvd., Newport Beach,
CA 92660.
Contact: Linda Hartley, Food and
Drug Administration, 19701 Fairchild,
Irvine, CA 92612, 949–608–4413, FAX:
949–608–4417, or OCRA, Attention to
Detail (ATD), 5319 University Dr., suite
641, Irvine, CA 92612, 949–387–9046,
FAX: 949–387–9047, Web site:
www.ocra-dg.org.
Registration and Meeting Information:
See OCRA Web site at www.ocra-dg.org.
Contact ATD at 949–387–9046.
Before April 24, 2006, registrations
fees are as follows: $525.00 for
members, $575.00 for nonmembers, and
$350.00 for FDA/government/full-time
students with the proper identification.
After April 24, 2006: $575.00 for
members, $625.00 for nonmembers, and
$350.00 for FDA/government/full-time
students with the proper identification.
The registration fee will cover actual
expenses including refreshments, lunch,
materials, parking, and speaker
expenses.
If you need special accommodations
due to a disability, please contact Linda
Hartley (see Contact) at least 10 days in
advance of the meeting.
The Ninth Annual Food and Drug
Administration–Orange County
Regulatory Affairs Educational
Conference
Dated: March 10, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–4092 Filed 3–21–06; 8:45 am]
Immediate Action
Therefore, pursuant to 41 CFR
71.32(b), HHS/CDC is amending the
February 4, 2004, order to add Albania,
Azerbaijan, Cameroon, and Myanmar to
the list of countries subject to the
order’s embargo of birds and productes
derived from birds. All other portions of
the February 4, 2004, order, as further
amended on March 10, 2004, September
28, 2004, December 29, 2005, February
8, 2006, February 22, 2006, February 27,
2006, and March 2, 2006 shall remain in
effect until further notice.
Dated: March 16, 2006.
Julie Louise Gerberding,
Director, Centers for Disease Control and
Prevention, U.S. Department of Health and
Human Services.
[FR Doc. 06–2767 Filed 3–21–06; 8:45 am]
BILLING CODE 4163–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
Food and Drug Administration,
BILLING CODE 4160–01–S
HHS.
ACTION:
Notice of meeting.
The Food and Drug Administration
(FDA) is announcing the following
conference: Ninth Annual Educational
Conference cosponsored with the
Orange County Regulatory Affairs
Discussion Group (OCRA). The
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 71, Number 55 (Wednesday, March 22, 2006)]
[Notices]
[Page 14533]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4092]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
The Ninth Annual Food and Drug Administration-Orange County
Regulatory Affairs Educational Conference
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing the following
conference: Ninth Annual Educational Conference cosponsored with the
Orange County Regulatory Affairs Discussion Group (OCRA). The
conference is intended to provide the drug, device, and biologics
industries with an opportunity to interact with FDA reviewers and
compliance officers from the centers and district offices, as well as
other industry experts. The main focus of this interactive conference
will be product approval, compliance, and risk management in the three
medical product areas. Industry speakers, interactive question and
answer, and workshop sessions will also be included to assure open
exchange and dialogue on the relevant regulatory issues.
Date and Time: The conference will be held on May 23 and 24, 2006,
from 7:30 a.m. to 5 p.m.
Location: The conference will be held at the Fairmont Newport Beach
Hotel, 4500 MacArthur Blvd., Newport Beach, CA 92660.
Contact: Linda Hartley, Food and Drug Administration, 19701
Fairchild, Irvine, CA 92612, 949-608-4413, FAX: 949-608-4417, or OCRA,
Attention to Detail (ATD), 5319 University Dr., suite 641, Irvine, CA
92612, 949-387-9046, FAX: 949-387-9047, Web site: www.ocra-dg.org.
Registration and Meeting Information: See OCRA Web site at
www.ocra-dg.org. Contact ATD at 949-387-9046.
Before April 24, 2006, registrations fees are as follows: $525.00
for members, $575.00 for nonmembers, and $350.00 for FDA/government/
full-time students with the proper identification. After April 24,
2006: $575.00 for members, $625.00 for nonmembers, and $350.00 for FDA/
government/full-time students with the proper identification.
The registration fee will cover actual expenses including
refreshments, lunch, materials, parking, and speaker expenses.
If you need special accommodations due to a disability, please
contact Linda Hartley (see Contact) at least 10 days in advance of the
meeting.
Dated: March 10, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-4092 Filed 3-21-06; 8:45 am]
BILLING CODE 4160-01-S
